IOSP — Innospec Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsBalancedMid CapContrarian

Annual income statement for Innospec, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,483	1,964	1,949	1,845	1,778
Cost of Revenue
Gross Profit	435	587	591	543	492
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,351	1,776	1,787	1,823	1,649
Operating Profit	132	187	162	22.3	130
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	134	185	174	41.2	138
Provision for Income Taxes
Net Income After Taxes	93.1	133	139	35.6	117
Net Income Before Extraordinary Items
Net Income	93.1	133	139	35.6	117
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	93.1	133	139	35.6	117
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.81	5.42	6.01	6.17	6.13
Dividends per Share